A surgeon in Michigan has performed the world’s first single-port robotic mitral valve repair.

The lawsuit Hemal Gada, MD, filed against UPMC has been dismissed with prejudice. 

Andy Morse, MD, the director of valvular and structural heart disease at Ascension Saint Thomas Hospital West in Nashville, leads a team that has performed more than 4,000 TAVR procedures. He spoke to Cardiovascular Business about recent findings on the long-term performance of the balloon-expandable SAPIEN 3™ platform.

Enlicitide, the new oral PCSK9 inhibitor from Merck, will be sold under the brand name Lipfendra. It is approved to reduce LDL-C in patients with hypercholesterolemia, including HeFH.

Researchers pointed to the many benefits of cardiology conferences and emphasized that they do not think these events are directly leading to patient deaths. However, they wrote, "increased attention on staffing during meetings is warranted."

Cath lab safety has been a significant concern among interventional cardiologists and other clinicians for many years now. Procedures are associated with significant radiation exposure, and the heavy aprons worn inside these labs can lead to painful orthopedic injuries. 

Data on the potential relationship between cannabis use and CVD remain mixed. For now, however, there is enough evidence available that heart patients should be careful. 

Cardiologists received a nice bump in pay in 2026 thanks to a one-time 2.5% conversion factor increase. That expires at the end of the year, however, and physicians will see their payments decrease as a result.

There has been progress over the years, researchers noted, but there is still a lot of work to do. 

The AI software, which has already received CE mark approval, provides care teams with a noninvasive way to secure FFR values from routine coronary angiography.